Cyclophosphamide After Sibling-donor allogeneic stem-cell Transplantation (CAST) in patients with acute leukaemia and myelodysplasia (CHERE)
Project Member(s): De Abreu Lourenco, R.
Funding or Partner Organisation: Medical Research Future Fund (Medical Research Future Fund- Rare Cancers, Rare Diseases and Unmet Need Grant Opportunity)
Medical Research Future Fund (Medical Research Future Fund- Rare Cancers, Rare Diseases and Unmet Need Grant Opportunity)
Start year: 2018
Summary: A randomised study comparing cyclosporin and methotrexate to cyclosporin and post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis.
FOR Codes: Applied Economics, Evaluation of Health Outcomes, Cancer and Related Disorders, Development studies, Policy and administration, Clinical health, Evaluation of health and support services